INAVOLISIB - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2025-05-05
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:25:52
Label at a glance#
ProductINAVOLISIB
Active ingredientINAVOLISIB
Products#
Every source-derived product name is available through these pages.
- INAVOLISIB
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| INAVOLISIB | L4C1UY2NYH | ACTIB |
| INAVOLISIB | L4C1UY2NYH | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Itovebi | INAVOLISIB | Genentech, Inc. | 5de59f5b-e5db-410f-b692-658686ef4107 | 2026-04-21 | Warnings, Adverse reactions | INAVOLISIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.